Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.
Hellen MusanaJude Thaddeus SsensambaMary NakafeeroHenry MugerwaFlavia Kiweewa MatovuDavid SerwaddaFrancis SsaliPublished in: AIDS research and therapy (2021)
Males and patients concomitantly on tuberculosis treatment while on second-line ART are at a higher risk of VF-M. HIV/AIDS response programs should give special attention to this group of people if we are to minimize the need for expensive third-line ART. We recommend more extensive, explorative studies to ascertain underlying factors.
Keyphrases
- hiv aids
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv infected patients
- hiv positive
- end stage renal disease
- ejection fraction
- newly diagnosed
- public health
- chronic kidney disease
- mycobacterium tuberculosis
- emergency department
- combination therapy
- drug induced
- south africa
- men who have sex with men